• News

    • Tandem Diabetes Care Announces Closing of Underwritten Public Offering of Common Stock

      March 4, 2015

      Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced the closing of its previously announced underwritten public offering of 6,037,500 shares of common stock at a price to the public of $11.50 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 787,500 shares. All of the shares in the offering were offered by Tandem.

      More

    • Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock

      March 2, 2015

      Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced that the underwriters of its previously announced public offering of common stock have exercised their option to purchase an additional 787,500 shares of its common stock at a price to the public of $11.50 per share. The net proceeds to Tandem from the offering is expected to be $64.8 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by Tandem. All of the shares of common stock to be sold in the offering are being offered by Tandem. The offering is expected to close on or about March 4, 2015, subject to customary closing conditions.

      More

    • Tandem Diabetes Care to Present at the Cowen and Company 35th Annual Health Care Conference

      February 27, 2015

      Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced that Kim Blickenstaff, president and CEO, will present a company update at the Cowen and Company 35th Annual Health Care Conference in Boston, MA. The presentation will take place on Tuesday, March 3, 2015 at 9:20am Eastern Time (6:20am Pacific Time).

      More

    • Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock

      February 26, 2015

      Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced the pricing of an underwritten public offering of 5,250,000 shares of its common stock at a price to the public of $11.50 per share. The net proceeds to Tandem from this offering are expected to be $56.3 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by Tandem. All of the shares of common stock to be sold in the offering are being offered by Tandem. In addition, Tandem has granted the underwriters a 30-day option to purchase up to an additional 787,500 shares of common stock. The offering is expected to close on or about March 4, 2015, subject to customary closing conditions.

      More

    • Tandem Diabetes Care Reports Fourth Quarter and Full Year 2014 Financial Results

      February 24, 2015

      Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today reported its financial results for the quarter and year ended December 31, 2014.

      More